Book of the month Wellcome Witnesses to Twentieth Century Medicine, Vols I and 2
Scientific papers have become constricted into straitjackets, a rigid format concealing the tortuous processes by which discoveries are made-exposed by Medawar's paper 'Is the scientific paper a fraud?'. Historians of contemporary medicine are therefore returning to oral history to supplement and extend existing records. Wellcome Witnesses1
is not the book of the month, or of the year. It is about origins, developments and realizations in medical science and practice of this century.
In witness seminars, individuals associated with a particular set ofcircumstances or events are invited to discuss, debate, and even disagree about their reminiscences. The History of the Twentieth Century Medicine Group, inaugurated by the Wellcome Trust in 1990, began its seminars with a meeting on monoclonal antibodies. So successful was the venture that further topics were arranged when an adequate quorum could be gathered. Invited speakers were requested not to prepare a formal presentation manuscripts and slides not being allowed because they disrupt interchange of views (conference organizers please note). Each half-day seminar developed its own kinetics and directions, depending on the interplay of participants. Seminars were then edited for publication, with addition of references and sometimes new material. The topics in volumes 1 and 2 are monoclonal antibodies, autoimmunity, endogenous opiates, the Committee on Safety ofDrugs, nuclear and magnetic resonance imaging, research in general practice, drugs in psychiatry, and the MRC Common Cold Unit. The seminars cannot adequately be summarized here, and some are highly technical. I have selected three to give you the flavour of the open, frank discussion. I am sure you will share my fascination with these volumes and find some surprises. Milstein proffers a few pearls: 'Laziness is the mother of good science. Creation comes from moments when you don't have anything to do' meaning freedom from teaching and administration. He advises inventing subjects and crossing disciplinary boundaries but shunning pressure to publish and empire-building. He concludes with 'keep the scientist a scientist and change things around him', by which I think he means do not let him become a business entrepreneur. Finally he quotes Sanger, 'Do good experiments and don't worry about anything else'.
Monclonal antibodies

Autoimmunity
The seminar on 'Self and Non-Self, a History of Autoimmunity' traces the development of ideas in modern immunology. It describes the interplay of diverse disciplines and how and where people met to exchange ideas, and outlines antagonistic views and some remaining gaps in knowledge. Roitt, the co-discoverer of thyroid autoantibody, opens the seminar by lauding Ehrlich's appreciation of the body having to distinguish self from non-self; Ehrlich coined Horror autotoxicus whereby the organism prevented self injury when it produced antibodies. Until 1940 immunology was predominantly a chemical discipline. Charles Darwin in his autobiography3 wrote that he followed a golden rule that 'whenever a published fact, a new observation or thought came across me, which was opposed to my general results, to make a memorandum of it without fail and at once; for I had found with experience that such facts and thoughts were far more apt to escape from the memory than favourable ones. If autoimmunity turns out to be an epiphenomenon, we are left with the shattering thought that medical scientists have been chasing a secondary effect for half a century, thus hindering a search for the underlying cause of diseases such as multiple sclerosis and rheumatoid arthritis.
General practice
The seminar on research in general practice is depressing. Morrell, on entering general practice, found 'What I had learnt in hospital was totally irrelevant. . . or just didn't work'. He thanks W S Peart for being 'one of the few medical educators who actually taught me to think'. Peart's research, while in general practice, on rabbits' kidneys did not appeal to Morrell but stimulated him to keep a notebook in which he recorded patients' names under backache, headache, feeling tired and other symptoms. The unhelpfulness of books on differential diagnosis drove him to start research on his own.
Marinker, needing help with 'boring repeat-prescription' and 'heartsink' patients, turned to Balint's psychiatric seminars. By contrast, W 0 Williams thought it was 'important to cultivate inquisitiveness during your daily work by taking notice of unusual deviations', which took him into epidemiology. The importance of 'academic general practice' is repeatedly stressed, yet 'academic' can be defined as abstract, impractical, theoretical, cold, or merely logical, and 'academical' means to belong to a college or university costume. This is all too clear when Metcalfe, a retired professor in general practice, supports a previous speaker with 'the point of the need for much more eclecticism in the methodologies we espouse'; and 'we have ignored methodologies from things like social psychology and social anthropology, which will give us a lot of insight into every day stuff that we meet in general practice'. I'll leave you to decide your own response to such sentiments.
Speakers emerge in their true colours when they discuss the opposition by the Royal Colleges to the foundation of a College of General Practitioners. Unfortunately GPs are Medawar, Billingham, and Brent. Owen never gained recognition, whereas according to Medawar's quip, Burnet was 'the man that shared my Nobel prize'.
Roitt recalls the accidents that brought him, Deborah Doniach and Campbell together, and led to their discovery of thyroid autoantibodies in patients with Hashimoto's disease. Doniach, working with a clinician and measuring thyroid metabolism, admired Hashimoto's 1912 paper as 'a model of clear thinking and of stimulating scientific discussion'. She had the advantage of being married to a histopathologist. Further, plasma cells that infiltrated the diseased thyroid had recently been found to make antibodies, which fitted into Campbell's research on milk proteins. Hence Roitt's emphasis on the value of the right mix and 'critical mass of people who are multidisciplinary and whose minds are not fixed only on their subject'. Campbell recalls chatting with Medawar and Brent in a pub near University College. Roitt describes Humphrey, director of immunology at Mill Hill, throwing out ideas like confetti; 'you didn't have the present day situation where you are frightened of telling anyone anything, because they might crawl into a corner and patent it'.
The discussion widens to include lupus erythematosus, rheumatoid arthritis, tumour-specific antigens, histocompatibility antigens, human leucocyte antibodies, and multiple sclerosis (considered even today to be driven by immune processes). Interesting asides include how LE cells were discovered. Instead ofmaking smears at the bedside as soon as bone marrow had been extracted, technicians at the Mayo Clinic put the aspirates into heparinized bottles which they carried around in their pockets. This provided time and temperature for some polymorphs to ingest altered nuclear material from other polymorphs in vitro. We also read about personal difficulties-jealousies among researchers, and failure ofimmunologists to get cooperation from histopathologists, particularly in the USA, Next we hear intellectual antibody salvoes. Coombs deplores 'the usage of this misconstrued, absurd and extremely confusing word "autoimmunity"', and asks 'How can you be immune to yourself?' He maintains that 'allergy' (altered reactivity) is the correct term-a biological response that can lead to protection and immunity, or to a harmful reaction and clinical hypersensitivity, or have no effect at all. (This is obvious in cardiac infarction where 50% of patients develop autoantibodies to cardiac muscle but under 0.5% get Dressler's syndrome a fact not mentioned by any discussant.) However, Lachmann comments that patients with total agammaglobulinaemia have no trouble in getting rid of dead cells. Also Roitt admits that the initiating mechanism of human Hashimoto's disease remains unknown. Yet I remember a paper claiming isolation of virus from the thyroid of such patients, not mentioned in this IJOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volume 92 April 1999 conditioned to an inferiority complex by teaching hospital consultants. What nonsense this is. GPs are specialists in minor ailments, early diagnosis, separating serious from benign conditions, distinguishing the organic from the psychogenic, which patients need a second or third opinion and from which specialist. GPs have many advantages over hospital doctors because they know the community, relatives and neighbours, as well as local beliefs and language. They have opportunities to see disease in the home, in the supermarket and in the street, hence they do not have to theorize or imagine the impact of illness they see it, in three dimensions. Moreover, with time (the fourth dimension) they can observe the evolution, progression or resolution of various conditions. However, they do have to cope with patients sent back from hospital with unhelpful letters replete with non-illuminating investigation results. Regrettably Henry Head's remark at the beginning of the century remains true 'Choose something common, you'll find nobody knows anything about it'.
We can still learn from past great figures. James Mackenzie revolutionized cardiology by direct observation, strapping a smoked drum to the back of his bicycle when he visited his Burnley patients. Pickles gathered valuable information on incubation periods and modes of transmission while a GP to five villages in Wensleydale. And Parkinson, 180 years ago, sitting in London's Hoxton Square, saw 3 of his 6 cases with 'the shaking palsy'; his description has still not been bettered. None required cooperative partners, vast series, statistics, computer or animal models, or attachment to academic departments of teaching hospitals. Disillusioned with consultant practice in London, Sir James Mackenzie returned to general practice.
Advice from Hachinski to a newly qualified doctor is invaluable: 'Distinguish information from knowledge and wisdom. Information is overwhelming but largely trivial and retrievable. Knowledge is understanding and wisdom cannot be taught, but can be acquired'4.
Dr Tilly Tansey deserves congratulations and thanks for initiating and carrying through these seminars (may we have more). We are privileged to read-no, to hear-scientists talking with contemporary colleagues about memories of discoveries, as well as groping towards understanding and misunderstandings. Doubts and contradictions, occasionally uttered, provide seeds for further progress. Above all history is shown not to be dust-dry or sterile. Few books are so intellectually stimulating or uplifting.
J N Blau
Private Consulting Rooms, National Hospital, Queen Square, London WC1 N 3BG, UK Microalbuminuria is the most recently described of the serious diabetic microvascular complications. The concept followed the development by Professor Harry Keen in 1963 of a radioimmunoassay for the measurement of small concentrations of urinary albumin. Clinical application of this measurement was slow to be realized but in the 1 970s several researchers, notably Professor Carl Eric Mogensen, reported increased urinary albumin excretion in patients with type 1 diabetes. The early 1 980s saw the demonstration of the predictive power of microalbuminuria for the development of later full-blown diabetic nephropathy in both type 1 and type 2 diabetes. Since then there has been an explosion of interest and research into this subject with particular attention being paid to patients with type 2 diabetes in relation to cardiovascular disease. There is no doubt that the presence of microalbuminuria is an important risk-factor in any patient with diabetes and the degree of risk is proportionate to the type and duration of diabetes and the constellation of other vascular risk factors that frequently accompany this complication.
As pointed out by Professor George Alberti in the foreword to Winocour and Marshall's comprehensive and fact-filled book, the term microalbuminuria is somewhat erroneous. The urinary albumin is not small in size, rather it is present in low concentration-concentrations far below those detected with conventional dip-sticks. Danish researchers tried to change the name to 'incipient nephropathy' but not surprisingly 'microalbuminuria' stuck despite the inaccuracy and potential for mispronunciation and mis-spelling. Peter Winocour and Sally Marshall previously worked together in Professor Alberti's department in Newcastle and both made substantial research contributions. They are thus well equipped to provide a comprehensive review of microalbuminuria in relation to diabetes and general medicine.
